Top 5 Small-Cap Stocks with Highest Upside Potential

10. Accolade Inc. (NASDAQ:ACCD)

[{"selector":"#anim-b4c3e118-8bec-43da-9a3a-8f2ff1966488 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(34.2054617809922%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-066593b4-dee5-421b-88f6-92141921ce67","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

9. Editas Medicine, Inc. (NASDAQ:EDIT)

[{"selector":"#anim-5070392e-e2fe-4830-a9d5-27106c9c1fe6 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(31.249999886225726%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-b31e4632-5518-40bc-9c0b-a248df5a9084","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

8. Arvinas, Inc. (NASDAQ:ARVN)

[{"selector":"#anim-7b8208d6-0c35-489f-9a34-2110604bb25c [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(8.718922401441736%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-fedd5638-132f-4d1a-8150-1490829fec07","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

7. Shoals Technologies Group, Inc. (NASDAQ:SHLS)

[{"selector":"#anim-b8dded86-886a-485d-ab48-74b01fefaaa8 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(31.19028651006721%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-98cd5fc9-92fa-4361-a4c3-7cb1c767d47e","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

6. ChargePoint Holdings, Inc. (NYSE:CHPT)

[{"selector":"#anim-be9b99c0-cfbc-477b-a75b-f6781e924b4e [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(31.249999886225726%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-ec7eb1fd-381a-4854-bb33-07e2d1c47b0a","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

5. Viridian Therapeutics, Inc. (NASDAQ:VRDN)

[{"selector":"#anim-abc7f1a5-7384-4d1d-bdb7-52bcff567aef [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(28.90624987200394%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-18e815d4-89d4-4ccb-9d94-46ba2fd1fa8d","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]